Developing AI Algorithms for Early Detection of Neurodegenerative Diseases

International Journal of Nursing and Health Science
© 2024 by SSRG - IJNHS Journal
Volume 10 Issue 3
Year of Publication : 2024
Authors : Vedamurthy Gejjegondanahalli Yogeshappa
pdf
How to Cite?

Vedamurthy Gejjegondanahalli Yogeshappa, "Developing AI Algorithms for Early Detection of Neurodegenerative Diseases," SSRG International Journal of Nursing and Health Science, vol. 10,  no. 3, pp. 6-18, 2024. Crossref, https://doi.org/10.14445/24547484/IJNHS-V10I3P102

Abstract:

It is very crucial to diagnose neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington diseases, in their early stages. These diseases are not easily diagnosed with traditional diagnostic techniques and are usually only diagnosed when they are more advanced, further negating patient outcomes. The solution to this problem is Artificial Intelligence (AI), which can propose tools that will analyze the data paramount in the medical field with precision and in a relatively shorter time than what might be required by a human being. This paper also presents recent work on designing novel AI algorithms specific to neurodegenerative diseases, showing the possibility of dramatically changing neurological diagnosis in the future. The research explores using ML and DL to analyze medical images, genomic data, and electronic health records (EHRs). Applying AI with neuroimaging techniques, including MRI, PET, and CT scans, allows for detecting subtle markers related to neurodegenerative profiles that may not be captured if they use basic clinical tools. Further, AI can be applied to EHR data and genetic sequencing information to define patterns and expose factors that may lead to these diseases. This research also tackles the question of the use of ethical AI in healthcare, the issues of data ownership, the explanation of the algorithm, and fairness. In order to achieve these goals, the paper will consider these challenges as the main points of the discussion section to present the usage of AI in clinical practice responsibly. In this paper, the author systematically reviews the recent AI solutions in diagnosing neurodegenerative diseases based on statistical analysis of their performance, applicability and concerns. There are methodological enhancements described concerning a broad-spectrum solution that may hold the best solution utilizing a combination approach of several AI techniques for enhanced diagnostic accuracy. The findings suggest that AI algorithms appear capable of achieving early detection with relatively high sensitivity and specificity and better than existing diagnostic instruments. The focus is on the clinical relevance of these findings, along with the directions for future research to improve the application of AI in ND care.

Keywords:

Neurodegenerative diseases, Artificial Intelligence (AI), Machine Learning (ML), Deep Learning (DL), Early detection, Neuroimaging, Biomarkers, Data privacy.

References:

[1] R. Jack Jr Clifford et al., “NIA-AA Research Framework: Toward a Biological Definition of Alzheimer's Disease,” The Journal of the Alzheimer's Association, vol. 14, no. 4, pp. 535-562, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[2] Guy M. McKhann et al., “The Diagnosis of Dementia Due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer's Disease,” Alzheimer's & Dementia, vol. 7, no. 3, pp. 263-269, 2011.
[CrossRef] [Google Scholar] [Publisher Link]
[3] Joseph Jankovic, “Parkinson’s Disease: Clinical Features and Diagnosis,” Journal of Neurology, Neurosurgery & Psychiatry, vol. 79, no. 4, pp. 368-376, 2008.
[CrossRef] [Google Scholar] [Publisher Link]
[4] Giovanni B. Frisoni et al., “The Clinical Use of Structural MRI in Alzheimer Disease,” Nature Reviews Neurology, vol. 6, no. 2, pp. 67 77, 2010.
[CrossRef] [Google Scholar] [Publisher Link]
[5] Ludovico Minati et al., “Reviews: Current Concepts in Alzheimer's Disease: A Multidisciplinary Review,” American Journal of Alzheimer's Disease & Other Dementias,” vol. 24, no. 2, pp. 95-121, 2009.
[CrossRef] [Google Scholar] [Publisher Link]
[6] Geert Litjens et al., “A Survey on Deep Learning in Medical Image Analysis,” Medical Image Analysis, vol. 42, pp. 60-88, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[7] Daniele Ravi et al., “Deep Learning for Health Informatics,” IEEE Journal of Biomedical and Health Informatics, vol. 21, no. 1, pp. 4 21. 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[8] Andre Esteva et al., “A Guide to Deep Learning in Healthcare,” Nature Medicine, vol. 25, no. 1, pp. 24-29, 2017.
[CrossRef] [Google Scholar] [Publisher Link]
[9] Monika A. Myszczynska et al., “Applications of Machine Learning to Diagnosis and Treatment of Neurodegenerative Diseases,” Nature Reviews Neurology, vol. 16, no. 8, pp. 440-456, 2020.
[CrossRef] [Google Scholar] [Publisher Link]
[10] Joeky T. Senders et al., “An Introduction and Overview of Machine Learning in Neurosurgical Care,” Acta Neurochirurgica, vol. 160, pp. 29-38, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[11] Danton S. Char, Nigam H. Shah, and David Magnus, “Implementing Machine Learning in Health Care — Addressing Ethical Challenges,” The New England Journal of Medicine, vol. 378, no. 11, pp. 981-983, 2018.
[CrossRef] [Google Scholar] [Publisher Link]
[12] Eric J. Topo, “High-Performance Medicine: the Convergence of Human and Artificial Intelligence,” Nature Medicine, vol. 25, no. 1, pp. 44-56, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[13] Ziad Obermeyer, and Ezekiel J. Emanuel, “Predicting the Future — Big Data, Machine Learning, and Clinical Medicine,” The New England Journal of Medicine, vol. 375, no. 13, pp. 1216-1219, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[14] Sanchit Dhankhar et al., “Artificial Intelligence in the Management of Neurodegenerative Disorders,” CNS & Neurological Disorders - Drug Targets, vol. 23, no. 8, pp. 931-940, 2024.
[CrossRef] [Google Scholar] [Publisher Link]
[15] Rajat Vashistha et al., Chapter 5 - Artificial Intelligence Integration for Neurodegenerative Disorders,” Academic Press, Leveraging Biomedical and Healthcare Data, Elsevier Science, pp. 77-89, 2019.
[CrossRef] [Google Scholar] [Publisher Link]
[16] Olugbemi T. Olaniyan et al., Chapter 18 - Prevention and Diagnosis of Neurodegenerative Diseases Using Machine Learning Models, Academic Press, Artificial Intelligence for Neurological Disorders, Elsevier Science, pp. 289-304, 2023.
[CrossRef] [Google Scholar] [Publisher Link]
[17] Manuel Gomez-Rio et al., “Diagnosis of Neurodegenerative Diseases: The Clinical Approach,” Current Alzheimer Research, vol. 13, no. 5, pp. 469-474, 2016.
[CrossRef] [Google Scholar] [Publisher Link]
[18] Oskar Hansson, “Biomarkers for Neurodegenerative Diseases,” Nature Medicine, vol. 27, no. 6, pp. 954-963, 2021.
[CrossRef] [Google Scholar] [Publisher Link]
[19] Vineet Dhanawat, “Ethical Considerations in AI and Ml: Bias Detection and Mitigation Strategies,” International Journal of Multidisciplinary Innovation and Research Methodology, vol. 2, no. 3, pp. 61-65, 2023.
[Google Scholar] [Publisher Link]
[20] Andrea Termine et al., “Multi-Layer Picture of Neurodegenerative Diseases: Lessons from the Use of Big Data Through Artificial Intelligence,” Journal of Personalized Medicine, vol. 11, no. 4, pp. 1-19, 2021.
[CrossRef] [Google Scholar] [Publisher Link]